This Article Full Text Full Text (PDF) All Versions of this Article: 149/9/4421    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Google Scholar Articles by Omoto, Y. PubMed PubMed Citation Articles by Omoto, Y.

Estrogen Receptor- Signaling in Growth of the Ventral Prostate: Comparison of Neonatal Growth and Postcastration Regrowth

Department of BioSciences and Nutrition, Karolinska University Hospital, Huddinge, Karolinska Institutet, SE-14186 Huddinge, Sweden

Address all correspondence and requests for reprints to: Yoko Omoto, Department of BioSciences and Nutrition, Karolinska University Hospital, Huddinge, Karolinska Institutet, SE-14186 Huddinge, Sweden. E-mail: yoko.omoto{at}mednut.ki.se.

A role for estrogen receptor (ER)- in branching morphogenesis in the ventral prostate (VP) has previously been demonstrated; in the VP of ER^–/– mice, there are fewer side branches than in wild-type littermates. In the present study, we show that in the postnatal VP, fibroblast growth factor 10 (FGF10) is expressed in wild-type mice but not in ER^–/– mice, and because branching involves proliferation pathways also used in malignant growth, we investigated whether branching during regrowth of the VP after castration involves ER and FGF10. ER was not detectable in the prostates of sham-operated or castrated mice but was expressed in the prostatic epithelium between d 3 and 5 after testosterone replacement. Blocking either ER or ERβ with ICI 182,780 had no detectable effects on epithelial cell proliferation during regrowth by testosterone. The ER agonist, propylpyrazoletriol, did not induce regrowth by itself, but exposure to propylpyrazoletriol on d 3–5 of testosterone replacement resulted in cyclin D1-positive cells in the ductal epithelium, invasion of FGF10-positive immune cells in the regrowing prostate, and budding 14 d later. Testosterone replacement alone did not induce cyclin D1, FGF10, or bud formation. These results indicate that stimulation of ER is essential for ductal branching during postnatal prostate growth. During regrowth after castration, there is a window in time when selective stimulation of ER can also induce ductal branching. The FGF10 for this growth comes from the immune system, not from the prostatic mesenchyme.